Point72 Asset Management »

Atara Biotherapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $331k 18k 18.09

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
Marshall Wace
Globeflex Capital
BlackRock
Geode Capital Management
Mackenzie Financial
Acadian Asset Management
Staley Capital Advisers
Renaissance Technologies
State Street Corporation
Cambridge Investment Research Advisors
Quadrature Capital
Point72 Asset Management

View all funds holding Atara Biotherapeutics